-
1
-
-
14244260176
-
Psoriatic arthritis: Epidemiology, clinical features, course, and outcome
-
Gladman, D. D., Antoni, C., Mease, P., Clegg, D. O. & Nash, P. Psoriatic arthritis: Epidemiology, clinical features, course, and outcome. Ann. Rheum. Dis. 64, (Suppl. 2), ii14-ii17 (2005).
-
(2005)
Ann. Rheum. Dis.
, vol.64
, pp. ii14-ii17
-
-
Gladman, D.D.1
Antoni, C.2
Mease, P.3
Clegg, D.O.4
Nash, P.5
-
2
-
-
0034023936
-
Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms
-
Scarpa, R. et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J. Rheumatol. 27, 1241-1246 (2000).
-
(2000)
J. Rheumatol.
, vol.27
, pp. 1241-1246
-
-
Scarpa, R.1
-
3
-
-
0036178901
-
Clinical features and predictive factors in psoriatic arthritis-related uveitis
-
Queiro, R. et al. Clinical features and predictive factors in psoriatic arthritis-related uveitis. Semin. Arthritis Rheum. 31, 264-270 (2002).
-
(2002)
Semin. Arthritis Rheum.
, vol.31
, pp. 264-270
-
-
Queiro, R.1
-
4
-
-
33750400902
-
Metabolic disorders in patients with psoriasis and psoriatic arthritis
-
Mallbris, L., Ritchlin, C. T. & Ståhle, M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr. Rheumatol. Rep. 8, 355-363 (2006).
-
(2006)
Curr. Rheumatol. Rep.
, vol.8
, pp. 355-363
-
-
Mallbris, L.1
Ritchlin, C.T.2
Ståhle, M.3
-
5
-
-
32144445910
-
Psoriasis psoriatic arthritis, or psoriatic disease?
-
Scarpa, R., Ayala, F., Caporaso, N. & Olivieri, I. Psoriasis, psoriatic arthritis, or psoriatic disease? J. Rheumatol. 33, 210-212 (2006).
-
(2006)
J. Rheumatol.
, vol.33
, pp. 210-212
-
-
Scarpa, R.1
Ayala, F.2
Caporaso, N.3
Olivieri, I.4
-
6
-
-
67449128733
-
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection
-
Rudwaleit, M. et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann. Rheum. Dis. 68, 777-783 (2009).
-
(2009)
Ann. Rheum. Dis.
, vol.68
, pp. 777-783
-
-
Rudwaleit, M.1
-
7
-
-
78650679234
-
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general
-
Rudwaleit, M. et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 70, 25-31 (2011).
-
(2011)
Ann. Rheum. Dis.
, vol.70
, pp. 25-31
-
-
Rudwaleit, M.1
-
8
-
-
0038603010
-
Progression of peripheral joint disease in psoriatic arthritis
-
McHugh, N. J., Balachrishnan, C. & Jones, S. M. Progression of peripheral joint disease in psoriatic arthritis. Rheumatology (Oxford) 42, 778-783 (2003).
-
(2003)
Rheumatology (Oxford)
, vol.42
, pp. 778-783
-
-
McHugh, N.J.1
Balachrishnan, C.2
Jones, S.M.3
-
9
-
-
0025299131
-
Longitudinal study of clinical and radiological progression in psoriatic arthritis
-
Gladman, D. D., Stafford-Brady, F., Chang, C. H., Lewandoswski, K. & Russell, M. L. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J. Rheumatol. 17, 809-812 (1990).
-
(1990)
J. Rheumatol.
, vol.17
, pp. 809-812
-
-
Gladman, D.D.1
Stafford-Brady, F.2
Chang, C.H.3
Lewandoswski, K.4
Russell, M.L.5
-
10
-
-
0025800559
-
Psoriatic arthritis (PA): A clinical, immunological and radiological study of 180 patients
-
Torre-Alonso, J. C. et al. Psoriatic arthritis (PA): A clinical, immunological and radiological study of 180 patients. Br. J. Rheumatol. 30, 245-250 (1991).
-
(1991)
Br. J. Rheumatol.
, vol.30
, pp. 245-250
-
-
Torre-Alonso, J.C.1
-
11
-
-
0030767275
-
Mortality studies in psoriatic arthritis: Results from a single outpatient clinic. I. Causes and risk of death
-
Wong, K., Gladman, D. D., Husted, J., Long, J.A. & Farewell, V. T. Mortality studies in psoriatic arthritis: Results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum. 40, 1868-1872 (1997).
-
(1997)
Arthritis Rheum.
, vol.40
, pp. 1868-1872
-
-
Wong, K.1
Gladman, D.D.2
Husted, J.3
Long, J.A.4
Farewell, V.T.5
-
12
-
-
0031802067
-
Mortality studies in psoriatic arthritis: Results from a single outpatient center. II. Prognostic indicators for death
-
Gladman, D. D., Farewell, V. T., Wong, K. & Husted, J. Mortality studies in psoriatic arthritis: Results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum. 41, 1103-1110 (1998).
-
(1998)
Arthritis Rheum.
, vol.41
, pp. 1103-1110
-
-
Gladman, D.D.1
Farewell, V.T.2
Wong, K.3
Husted, J.4
-
13
-
-
33745782642
-
Disability and quality of life considerations. Psoriatic arthritis
-
(eds Gordon, G. B. & Ruderman, E.) (Springer-Verlag, Heidelberg
-
Gladman, D. D. Disability and quality of life considerations. Psoriatic arthritis. In Psoriasis and Psoriatic Arthritis: An Integrated Approach (eds Gordon, G. B. & Ruderman, E.) 118-123 (Springer-Verlag, Heidelberg 2005).
-
(2005)
Psoriasis and Psoriatic Arthritis: An Integrated Approach
, pp. 118-123
-
-
Gladman, D.D.1
-
14
-
-
37749019317
-
Lower limbs enthesopathy in patients with psoriasis without clinical signs of arthropathy: An hospital-based case-control study
-
Gisondi, P. et al. Lower limbs enthesopathy in patients with psoriasis without clinical signs of arthropathy: An hospital-based case-control study. Ann. Rheum. Dis. 67, 26-30 (2008).
-
(2008)
Ann. Rheum. Dis.
, vol.67
, pp. 26-30
-
-
Gisondi, P.1
-
15
-
-
77955488365
-
Beyond early diagnosis: Occult psoriatic arthritis
-
Palazzi, C., Lubrano, E., D'Angelo, S. & Olivieri, I. Beyond early diagnosis: Occult psoriatic arthritis. J. Rheumatol. 37, 1556-1558 (2010).
-
(2010)
J. Rheumatol.
, vol.37
, pp. 1556-1558
-
-
Palazzi, C.1
Lubrano, E.2
D'Angelo, S.3
Olivieri, I.4
-
16
-
-
64849094127
-
Epidemiology and clinical pattern of psoriatic arthritis in Germany: A prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis
-
Reich, K., Kruger, K., Mossner, R. & Augustin, M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: A prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br. J. Dermatol. 160, 1040-1047 (2009).
-
(2009)
Br. J. Dermatol.
, vol.160
, pp. 1040-1047
-
-
Reich, K.1
Kruger, K.2
Mossner, R.3
Augustin, M.4
-
17
-
-
77950795910
-
The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics
-
Christophers, E. et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J. Eur. Acad. Dermatol. Venereol. 24, 548-554 (2010).
-
(2010)
J. Eur. Acad. Dermatol. Venereol.
, vol.24
, pp. 548-554
-
-
Christophers, E.1
-
18
-
-
84875956855
-
High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires
-
Haroon, M., Kirby, B. & FitzGerald, O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann. Rheum. Dis. 72, 736-740 (2013).
-
(2013)
Ann. Rheum. Dis.
, vol.72
, pp. 736-740
-
-
Haroon, M.1
Kirby, B.2
FitzGerald, O.3
-
19
-
-
34548538646
-
The PASE questionnaire: Pilot-testing a psoriatic arthritis screening and evaluation tool
-
Husni, M. E., Meyer, K. H., Cohen, D. S., Mody, E. & Qureshi, A. A. The PASE questionnaire: Pilot-testing a psoriatic arthritis screening and evaluation tool. J. Am. Acad. Dermatol. 57, 581-587 (2007).
-
(2007)
J. Am. Acad. Dermatol.
, vol.57
, pp. 581-587
-
-
Husni, M.E.1
Meyer, K.H.2
Cohen, D.S.3
Mody, E.4
Qureshi, A.A.5
-
20
-
-
69049097129
-
Validity reliability, and sensitivity-to change properties of the psoriatic arthritis screening and evaluation questionnaire
-
Dominguez, P. L., Husni, M. E., Holt, E. W., Tyler, S. & Qureshi, A. Validity, reliability, and sensitivity-to change properties of the psoriatic arthritis screening and evaluation questionnaire. Arch. Dermatol. Res. 301, 573-579 (2009).
-
(2009)
Arch. Dermatol. Res.
, vol.301
, pp. 573-579
-
-
Dominguez, P.L.1
Husni, M.E.2
Holt, E.W.3
Tyler, S.4
Qureshi, A.5
-
21
-
-
65249091381
-
Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS)
-
Gladman, D. D. et al. Development and initial validation of a screening questionnaire for psoriatic arthritis: The Toronto Psoriatic Arthritis Screen (ToPAS). Ann. Rheum. Dis. 68, 497-501 (2009).
-
(2009)
Ann. Rheum. Dis.
, vol.68
, pp. 497-501
-
-
Gladman, D.D.1
-
22
-
-
84881456912
-
Dermatology screening tools: Project update from GRAPPA 2012 annual meeting
-
Gladman, D. D., Helliwell, P. S., Khraishi, M., Callis Duffin, K. & Mease, P. J. Dermatology screening tools: Project update from GRAPPA 2012 annual meeting. J. Rheumatol. 40, 1425-1427 (2013).
-
(2013)
J. Rheumatol.
, vol.40
, pp. 1425-1427
-
-
Gladman, D.D.1
Helliwell, P.S.2
Khraishi, M.3
Callis Duffin, K.4
Mease, P.J.5
-
23
-
-
67651171603
-
Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: The Psoriasis Epidemiology Screening Tool (PEST) questionnaire
-
Ibrahim, G. H., Buch, M. H., Lawson, C., Waxman, R. & Helliwell, P. S. Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: The Psoriasis Epidemiology Screening Tool (PEST) questionnaire. Clin. Exp. Rheumatol. 27, 469-474 (2009).
-
(2009)
Clin. Exp. Rheumatol.
, vol.27
, pp. 469-474
-
-
Ibrahim, G.H.1
Buch, M.H.2
Lawson, C.3
Waxman, R.4
Helliwell, P.S.5
-
24
-
-
79956048725
-
The electronic Psoriasis and Arthritis Screening Questionnaire (ePASQ): A sensitive and specific tool to diagnose psoriatic arthritis patients
-
Khraishi, M., Mong, J., Mugford, G. & Landells, I. The electronic Psoriasis and Arthritis Screening Questionnaire (ePASQ): A sensitive and specific tool to diagnose psoriatic arthritis patients. J. Cutan. Med. Surg. 15, 143-149 (2011).
-
(2011)
J. Cutan. Med. Surg.
, vol.15
, pp. 143-149
-
-
Khraishi, M.1
Mong, J.2
Mugford, G.3
Landells, I.4
-
25
-
-
84867820789
-
The early psoriatic arthritis screening questionnarie: A simple and fast method for the identification of arthritis in patients with psoriasis
-
Tinazzi, I. et al. The early psoriatic arthritis screening questionnarie: A simple and fast method for the identification of arthritis in patients with psoriasis. Rheumatology 51, 2058-2063 (2012).
-
(2012)
Rheumatology
, vol.51
, pp. 2058-2063
-
-
Tinazzi, I.1
-
26
-
-
84875429609
-
Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study)
-
Coates, L. C. et al. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br. J. Dermatol. 168, 802-807 (2013).
-
(2013)
Br. J. Dermatol.
, vol.168
, pp. 802-807
-
-
Coates, L.C.1
-
27
-
-
84874851329
-
Limitations in screening instruments for psoriatic arthritis: A comparison of instruments in patients with psoriasis
-
Walsh, J. A., Callin Duffin, K., Krueger, G. G. & Clegg, D. O. Limitations in screening instruments for psoriatic arthritis: A comparison of instruments in patients with psoriasis. J. Rheumatol. 40, 287-293 (2013).
-
(2013)
J. Rheumatol.
, vol.40
, pp. 287-293
-
-
Walsh, J.A.1
Callin Duffin, K.2
Krueger, G.G.3
Clegg, D.O.4
-
28
-
-
33746951437
-
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
-
Taylor, W. et al. Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum. 54, 2665-2673 (2006).
-
(2006)
Arthritis Rheum.
, vol.54
, pp. 2665-2673
-
-
Taylor, W.1
-
29
-
-
84863838231
-
Performance of classification criteria for peripheral spondyloarthrtis and psoriatic arthritis in the Leiden Early Arthritis cohort
-
van der Berg, R., van Gaalen, F., van der Helm-van Mil, A., Huizinga, T. & van der Heijde, D. Performance of classification criteria for peripheral spondyloarthrtis and psoriatic arthritis in the Leiden Early Arthritis cohort. Ann. Rheum. Dis. 71, 1366-1369 (2012).
-
(2012)
Ann. Rheum. Dis.
, vol.71
, pp. 1366-1369
-
-
Van Der Berg, R.1
Van Gaalen, F.2
Van Der Helm-Van Mil, A.3
Huizinga, T.4
Van Der Heijde, D.5
-
30
-
-
84862499025
-
Classification and clinical assessment
-
Marchesoni, A. & Cantini, F. Classification and clinical assessment. Reumatismo 64, 79-87 (2012).
-
(2012)
Reumatismo
, vol.64
, pp. 79-87
-
-
Marchesoni, A.1
Cantini, F.2
-
31
-
-
37349081288
-
Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis
-
Chandran, V., Schentag, C. T. & Gladman, D. D. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum. 57, 1560-1563 (2007).
-
(2007)
Arthritis Rheum.
, vol.57
, pp. 1560-1563
-
-
Chandran, V.1
Schentag, C.T.2
Gladman, D.D.3
-
32
-
-
64849104327
-
Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis
-
D'Angelo, S. et al. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J. Rheumatol. 36, 368-370 (2009).
-
(2009)
J. Rheumatol.
, vol.36
, pp. 368-370
-
-
D'Angelo, S.1
-
33
-
-
84869030520
-
Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis
-
Coates, L. C. et al. Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum. 64, 3150-3155 (2012).
-
(2012)
Arthritis Rheum.
, vol.64
, pp. 3150-3155
-
-
Coates, L.C.1
-
34
-
-
58149394480
-
Can we identify psoriatic arthritis early?
-
Gladman, D. D. Can we identify psoriatic arthritis early? Curr. Rheumatol. Rep. 10, 419-421 (2008).
-
(2008)
Curr. Rheumatol. Rep.
, vol.10
, pp. 419-421
-
-
Gladman, D.D.1
-
35
-
-
65649122679
-
Treatment strategies for early psoriatic arthritis
-
Olivieri, I., D'Angelo, S., Palazzi, C. & Padula, A. Treatment strategies for early psoriatic arthritis. Expert Opin. Pharmacother. 10, 271-282 (2009).
-
(2009)
Expert Opin. Pharmacother.
, vol.10
, pp. 271-282
-
-
Olivieri, I.1
D'Angelo, S.2
Palazzi, C.3
Padula, A.4
-
36
-
-
70350746171
-
The diagnosis and treatment of early psoriatic arthritis
-
Anandarajah, A. P. & Ritchlin, C. T. The diagnosis and treatment of early psoriatic arthritis. Nat. Rev. Rheumatol. 5, 634-641 (2009).
-
(2009)
Nat. Rev. Rheumatol.
, vol.5
, pp. 634-641
-
-
Anandarajah, A.P.1
Ritchlin, C.T.2
-
37
-
-
77950307115
-
Treating rheumatoid arthritis to target: Recommendations of an international task force
-
Smolen, J. S. et al. Treating rheumatoid arthritis to target: Recommendations of an international task force. Ann. Rheum. Dis. 69, 631-637 (2010).
-
(2010)
Ann. Rheum. Dis.
, vol.69
, pp. 631-637
-
-
Smolen, J.S.1
-
38
-
-
77950309959
-
Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search
-
Shoels, M. et al. Evidence for treating rheumatoid arthritis to target: Results of a systematic literature search. Ann. Rheum. Dis. 69, 638-643 (2010).
-
(2010)
Ann. Rheum. Dis.
, vol.69
, pp. 638-643
-
-
Shoels, M.1
-
39
-
-
84889634412
-
Targeting spondyloarthtitis, including ankylosing spondylitis and psoriatic arthritis, to target: Recommendations of an international task force
-
Smolen, J. S. et al. Targeting spondyloarthtitis, including ankylosing spondylitis and psoriatic arthritis, to target: Recommendations of an international task force. Ann. Rheum. Dis. 73, 6-16 (2014).
-
(2014)
Ann. Rheum. Dis.
, vol.73
, pp. 6-16
-
-
Smolen, J.S.1
-
40
-
-
84889683977
-
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: Results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis
-
Schoels, M. M. et al. Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: Results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann. Rheum. Dis. 73, 238-242 (2014).
-
(2014)
Ann. Rheum. Dis.
, vol.73
, pp. 238-242
-
-
Schoels, M.M.1
-
41
-
-
73449100479
-
Defining minimal disease activity in psoriatic arthritis: A proposed objective target for treatment
-
Coates, L. C., Fransen, J. & Helliwell, P. S. Defining minimal disease activity in psoriatic arthritis: A proposed objective target for treatment. Ann. Rheum. Dis. 69, 48-53 (2010).
-
(2010)
Ann. Rheum. Dis.
, vol.69
, pp. 48-53
-
-
Coates, L.C.1
Fransen, J.2
Helliwell, P.S.3
-
42
-
-
0037233923
-
Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patient with early rheumatoid arthritis
-
Conaghan, P. G. et al. Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patient with early rheumatoid arthritis. Arthritis Rheum. 48, 64-71 (2003).
-
(2003)
Arthritis Rheum.
, vol.48
, pp. 64-71
-
-
Conaghan, P.G.1
-
43
-
-
3242677099
-
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomized controlled study
-
Grigor, C. et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomized controlled study. Lancet 364, 263-269 (2004).
-
(2004)
Lancet
, vol.364
, pp. 263-269
-
-
Grigor, C.1
-
44
-
-
0032722907
-
Progression in psoriatic arthritis: Role of time varying clinical indicators
-
Gladman, D. D. & Farewell, V. T. Progression in psoriatic arthritis: Role of time varying clinical indicators. J. Rheumatol. 26, 2409-2413 (1999).
-
(1999)
J. Rheumatol.
, vol.26
, pp. 2409-2413
-
-
Gladman, D.D.1
Farewell, V.T.2
-
45
-
-
34147208743
-
Predictors for radiological damage in psoriatic arthritis: Results from a single centre
-
Bond, S. J., Farewell, V. T., Schentag, C. T. & Gladman, D. D. Predictors for radiological damage in psoriatic arthritis: Results from a single centre. Ann. Rheum. Dis. 66, 370-376 (2007).
-
(2007)
Ann. Rheum. Dis.
, vol.66
, pp. 370-376
-
-
Bond, S.J.1
Farewell, V.T.2
Schentag, C.T.3
Gladman, D.D.4
-
46
-
-
84875181495
-
The TICOPA protocol (tight control of psoriatic arthritis): A randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis
-
Coates, L. C. et al. The TICOPA protocol (tight control of psoriatic arthritis): A randomised controlled trial to compare intensive management versus standard care in early psoriatic arthritis. BMC Musculoskelet. Disord. 14, 101 (2013).
-
(2013)
BMC Musculoskelet. Disord.
, vol.14
, pp. 101
-
-
Coates, L.C.1
-
47
-
-
84912126983
-
Results of a randomized controlled trial comparing tight control of early psoriatic arthrtis (TICOPA) with standard care: Tight control improves outcome [abstract]
-
Coates, L. C. et al. Results of a randomized controlled trial comparing tight control of early psoriatic arthrtis (TICOPA) with standard care: Tight control improves outcome [abstract]. Arthritis Rheum. 65, a814 (2013).
-
(2013)
Arthritis Rheum.
, vol.65
, pp. a814
-
-
Coates, L.C.1
-
48
-
-
82955236087
-
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
-
Gossec, L. et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann. Rheum. Dis. 71, 4-12 (2012).
-
(2012)
Ann. Rheum. Dis.
, vol.71
, pp. 4-12
-
-
Gossec, L.1
-
49
-
-
69949125952
-
Treatment recommendations for psoriatic arthritis
-
Ritchlin, C. T. et al. Treatment recommendations for psoriatic arthritis. Ann. Rheum. Dis. 68, 1387-1394 (2009).
-
(2009)
Ann. Rheum. Dis.
, vol.68
, pp. 1387-1394
-
-
Ritchlin, C.T.1
-
50
-
-
36849016433
-
Recommendations of the French Society for Rheumatology regarding TNFa antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update
-
Pham, T. et al. Recommendations of the French Society for Rheumatology regarding TNFa antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update. Joint Bone Spine 74, 638-646 (2007).
-
(2007)
Joint Bone Spine
, vol.74
, pp. 638-646
-
-
Pham, T.1
-
51
-
-
80055095434
-
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: Update from the Italian Society for Rheumatology
-
Salvarani, C. et al. Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: Update from the Italian Society for Rheumatology. Clin. Exp. Rheumatol. 29, (Suppl. 66), S28-S41 (2011).
-
(2011)
Clin. Exp. Rheumatol.
, vol.29
, pp. S28-S41
-
-
Salvarani, C.1
-
52
-
-
79953770834
-
Consensus statement of the Spanish society of Rheumatology on the management of biologic therapies in psoriatic arthritis
-
Fernández Sueiro, J. L. et al. Consensus statement of the Spanish society of Rheumatology on the management of biologic therapies in psoriatic arthritis. Rheumatol. Clin. 7, 179-188 (2011).
-
(2011)
Rheumatol. Clin.
, vol.7
, pp. 179-188
-
-
Fernández Sueiro, J.L.1
-
53
-
-
84862996511
-
2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis
-
Machado, P. et al. 2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis. Acta Rheumatol. Port. 37, 26-39 (2012).
-
(2012)
Acta Rheumatol. Port.
, vol.37
, pp. 26-39
-
-
Machado, P.1
-
54
-
-
84887539435
-
The 2012 BSR and BHPR guidelines for the treatment of psoriatic arthritis with biologics
-
Coates, L. C. et al. The 2012 BSR and BHPR guidelines for the treatment of psoriatic arthritis with biologics. Rheumatology 52, 1754-1757 (2013).
-
(2013)
Rheumatology
, vol.52
, pp. 1754-1757
-
-
Coates, L.C.1
-
55
-
-
80855151628
-
Measures of psoriatic arthritis: Tender and swollen joint assessment, psoriasis area and severity index (PASI)
-
Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI)
-
Mease, P. J. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res. (Hoboken) 63, (Suppl. 11) S64-S85 (2011).
-
(2011)
Arthritis Care Res. (Hoboken)
, vol.63
, pp. S64-S85
-
-
Mease, P.J.1
-
56
-
-
34248665535
-
Consensus on a core set of domains for psoriatic arthritis
-
Gladman, D. D. et al. Consensus on a core set of domains for psoriatic arthritis. J. Rheumatol. 34, 1167-1170 (2007).
-
(2007)
J. Rheumatol.
, vol.34
, pp. 1167-1170
-
-
Gladman, D.D.1
-
57
-
-
77949456275
-
Evaluation of the appropriateness for composite disease activity measures for assessment of psoriatic arthritis
-
Nell-Duxneuner, V. P. et al. Evaluation of the appropriateness for composite disease activity measures for assessment of psoriatic arthritis. Ann. Rheum. Dis. 69, 546-549 (2010).
-
(2010)
Ann. Rheum. Dis.
, vol.69
, pp. 546-549
-
-
Nell-Duxneuner, V.P.1
-
58
-
-
77955459298
-
Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis
-
Schoels, M. et al. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann. Rheum. Dis. 69, 1441-1447 (2010).
-
(2010)
Ann. Rheum. Dis.
, vol.69
, pp. 1441-1447
-
-
Schoels, M.1
-
59
-
-
78751701276
-
Development of a preliminary composite disease activity index in psoriatic arthritis
-
Mumtaz, A. et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann. Rheum. Dis. 70, 272-277 (2011).
-
(2011)
Ann. Rheum. Dis.
, vol.70
, pp. 272-277
-
-
Mumtaz, A.1
-
60
-
-
79952372121
-
Composite measures in psoriatic arthritis: A report from the GRAPPA 2009 annual meeting
-
Helliwell, P. S., Fitzgerald, O., Strand, C. V. & Mease, P. J. Composite measures in psoriatic arthritis: A report from the GRAPPA 2009 annual meeting. J. Rheumatol. 38, 540-545 (2011).
-
(2011)
J. Rheumatol.
, vol.38
, pp. 540-545
-
-
Helliwell, P.S.1
Fitzgerald, O.2
Strand, C.V.3
Mease, P.J.4
-
61
-
-
84877636515
-
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)
-
Helliwell, P. S. et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann. Rheum. Dis. 72, 986-991 (2013).
-
(2013)
Ann. Rheum. Dis.
, vol.72
, pp. 986-991
-
-
Helliwell, P.S.1
-
62
-
-
0017261080
-
A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter's disease
-
Lassus, A. A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter's disease. Curr. Med. Res. Opin. 4, 65-69 (1976).
-
(1976)
Curr. Med. Res. Opin.
, vol.4
, pp. 65-69
-
-
Lassus, A.1
-
63
-
-
0020075974
-
The run-in period in trial design: A comparison of two non-steroidal anti-inflammatory agents in psoriatic arthropathy
-
Leatham, P. A., Bird, H. A., Wright, V. & Fowler, P. D. The run-in period in trial design: A comparison of two non-steroidal anti-inflammatory agents in psoriatic arthropathy. Agents Actions 12, 221-224 (1982).
-
(1982)
Agents Actions
, vol.12
, pp. 221-224
-
-
Leatham, P.A.1
Bird, H.A.2
Wright, V.3
Fowler, P.D.4
-
64
-
-
0035065835
-
The role of NSAIDs in psoriatic arthritis: Evidence from a controlled study with nimesulide
-
Sarzi-Puttini, P., Santandrea, S., Boccassini, L., Panni, B. & Caruso, I. The role of NSAIDs in psoriatic arthritis: Evidence from a controlled study with nimesulide. Clin. Exp. Rheumatol. 19 (1 Suppl. 22), S17-S20 (2001).
-
(2001)
Clin. Exp. Rheumatol.
, vol.19
, Issue.1
, pp. S17-S20
-
-
Sarzi-Puttini, P.1
Santandrea, S.2
Boccassini, L.3
Panni, B.4
Caruso, I.5
-
65
-
-
36348982256
-
A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis
-
Kivitz, A. J., Espinoza, L. R., Sherrer, Y. R., Liu-Dumaw, M. & West, C. R. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis. Semin. Arthritis Rheum. 37, 164-173 (2007).
-
(2007)
Semin. Arthritis Rheum.
, vol.37
, pp. 164-173
-
-
Kivitz, A.J.1
Espinoza, L.R.2
Sherrer, Y.R.3
Liu-Dumaw, M.4
West, C.R.5
-
66
-
-
81155125087
-
Glucocorticoid treatment in spondyloarthritis
-
Fendler, C., Baraliakos, X. & Braun, J. Glucocorticoid treatment in spondyloarthritis. Clin. Exp. Rheumatol. 29, (5 Suppl. 68), S139-S142 (2011).
-
(2011)
Clin. Exp. Rheumatol.
, vol.29
, Issue.5
, pp. S139-S142
-
-
Fendler, C.1
Baraliakos, X.2
Braun, J.3
-
67
-
-
77954212051
-
Predictors of response to intra-articular steroid injection in psoriatic arthritis
-
Eder, L. et al. Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford) 49, 1367-1373 (2010).
-
(2010)
Rheumatology (Oxford)
, vol.49
, pp. 1367-1373
-
-
Eder, L.1
-
68
-
-
78650529461
-
Use of methotrexate in patients with psoriatic arthritis
-
Ceponis, A. & Kavanaugh, A. Use of methotrexate in patients with psoriatic arthritis. Clin. Exp. Rheumatol. 28, (5 Suppl. 61), S132-S137 (2010).
-
(2010)
Clin. Exp. Rheumatol.
, vol.28
, Issue.5
, pp. S132-S137
-
-
Ceponis, A.1
Kavanaugh, A.2
-
69
-
-
0028909238
-
Longterm methotrexate therapy in psoriatic arthritis: Clinical and radiological outcome
-
Abu-Shakra, M. et al. Longterm methotrexate therapy in psoriatic arthritis: Clinical and radiological outcome. J. Rheumatol. 22, 241-245 (1995).
-
(1995)
J. Rheumatol.
, vol.22
, pp. 241-245
-
-
Abu-Shakra, M.1
-
70
-
-
40649111400
-
Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: Results from a longitudinal observational cohort
-
Chandran, V., Schentag, C. T. & Gladman, D. D. Reappraisal of the effectiveness of methotrexate in psoriatic arthritis: Results from a longitudinal observational cohort. J. Rheumatol. 35, 469-471 (2008).
-
(2008)
J. Rheumatol.
, vol.35
, pp. 469-471
-
-
Chandran, V.1
Schentag, C.T.2
Gladman, D.D.3
-
71
-
-
84865186509
-
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis
-
Kingsley, G. H. et al. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) 51, 1368-1377 (2012).
-
(2012)
Rheumatology (Oxford)
, vol.51
, pp. 1368-1377
-
-
Kingsley, G.H.1
-
72
-
-
84860568139
-
Spondyloarthritis: Is methotrexate effective in psoriatic arthritis?
-
Mease, P. J. Spondyloarthritis: Is methotrexate effective in psoriatic arthritis? Nat. Rev. Rheumatol. 8, 251-252 (2012).
-
(2012)
Nat. Rev. Rheumatol.
, vol.8
, pp. 251-252
-
-
Mease, P.J.1
-
73
-
-
0034790695
-
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis
-
Salvarani, C. et al. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J. Rheumatol. 28, 2274-2282 (2001).
-
(2001)
J. Rheumatol.
, vol.28
, pp. 2274-2282
-
-
Salvarani, C.1
-
74
-
-
0036217529
-
Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis
-
Sarzi-Puttini, P. et al. Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritis. Rheumatol. Int. 21, 234-238 (2002).
-
(2002)
Rheumatol. Int.
, vol.21
, pp. 234-238
-
-
Sarzi-Puttini, P.1
-
75
-
-
21144451096
-
A randomized double blind, placebo controlled, multicenter trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis
-
Fraser, A. D. et al. A randomized double blind, placebo controlled, multicenter trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann. Rheum. Dis. 64, 859-864 (2005).
-
(2005)
Ann. Rheum. Dis.
, vol.64
, pp. 859-864
-
-
Fraser, A.D.1
-
76
-
-
84876308124
-
Leflunomide in psoriatic arthritis: Results from a large European prospective observational study
-
Behrens, F. et al. Leflunomide in psoriatic arthritis: Results from a large European prospective observational study. Arthritis Care Res. (Hoboken) 65, 464-470 (2013).
-
(2013)
Arthritis Care Res. (Hoboken)
, vol.65
, pp. 464-470
-
-
Behrens, F.1
-
77
-
-
2642558895
-
Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind, randomized, placebo-controlled clinical trial
-
Kaltwasser, J. P. et al. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: A multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum. 50, 1939-1950 (2004).
-
(2004)
Arthritis Rheum.
, vol.50
, pp. 1939-1950
-
-
Kaltwasser, J.P.1
-
78
-
-
84886728119
-
Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate
-
Sakellariou, G. T., Sayegh, F.E, Anastasilakis, A. D. & Kapetanos, G. A. Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate. Rheumatol. Int. 33, 2917-2920 (2013).
-
(2013)
Rheumatol. Int.
, vol.33
, pp. 2917-2920
-
-
Sakellariou, G.T.1
Sayegh, F.E.2
Anastasilakis, A.D.3
Kapetanos, G.A.4
-
79
-
-
0033511186
-
Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A Department of Veterans Affairs cooperative study
-
Clegg, D. O., Reda, D. J. & Abdellatif, M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A Department of Veterans Affairs cooperative study. Arthritis Rheum. 42, 2325-2329 (1999).
-
(1999)
Arthritis Rheum.
, vol.42
, pp. 2325-2329
-
-
Clegg, D.O.1
Reda, D.J.2
Abdellatif, M.3
-
80
-
-
0029054947
-
Sulfasalazine therapy for psoriatic arthritis: A double blind, placebo controlled trial
-
Gupta, A. K. et al. Sulfasalazine therapy for psoriatic arthritis: A double blind, placebo controlled trial. J. Rheumatol. 22, 894-898 (1995).
-
(1995)
J. Rheumatol.
, vol.22
, pp. 894-898
-
-
Gupta, A.K.1
-
81
-
-
0031752214
-
The use of sulfasalazine in psoriatic arthritis: A clinic experience
-
Rahman, P., Gladman, D. D., Cook, R. J., Zhou, Y. & Young, G. The use of sulfasalazine in psoriatic arthritis: A clinic experience. J. Rheumatol. 25, 1957-1961 (1998).
-
(1998)
J. Rheumatol.
, vol.25
, pp. 1957-1961
-
-
Rahman, P.1
Gladman, D.D.2
Cook, R.J.3
Zhou, Y.4
Young, G.5
-
82
-
-
84862487609
-
Psoriatic arthritis: Treatment strategies using biologic agents
-
D'Angelo, S., Palazzi, C. & Olivieri, I. Psoriatic arthritis: Treatment strategies using biologic agents. Reumatismo 64, 113-121 (2012).
-
(2012)
Reumatismo
, vol.64
, pp. 113-121
-
-
D'Angelo, S.1
Palazzi, C.2
Olivieri, I.3
-
83
-
-
84881650385
-
Psoriatic arthritis: Current therapy and future directions
-
Huynh, D. & Kavanaugh, A. Psoriatic arthritis: Current therapy and future directions. Expert Opin. Pharmacother. 14, 1755-1764 (2013).
-
(2013)
Expert Opin. Pharmacother.
, vol.14
, pp. 1755-1764
-
-
Huynh, D.1
Kavanaugh, A.2
-
84
-
-
84889668023
-
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)
-
Mease, P. J. et al. Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann. Rheum. Dis. 73, 48-55 (2014).
-
(2014)
Ann. Rheum. Dis.
, vol.73
, pp. 48-55
-
-
Mease, P.J.1
-
85
-
-
84891744277
-
Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: A systematic review and meta-analysis of randomised controlled trials
-
Goulabchand, R. et al. Effect of tumour necrosis factor blockers on radiographic progression of psoriatic arthritis: A systematic review and meta-analysis of randomised controlled trials. Ann. Rheum. Dis. 73, 414-419 (2014).
-
(2014)
Ann. Rheum. Dis.
, vol.73
, pp. 414-419
-
-
Goulabchand, R.1
-
86
-
-
77950860194
-
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs
-
Atteno, M. et al. Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. Clin. Rheumatol. 29, 399-403 (2010).
-
(2010)
Clin. Rheumatol.
, vol.29
, pp. 399-403
-
-
Atteno, M.1
-
87
-
-
84879994854
-
Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis
-
Fénix-Caballero, S. et al. Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis. J. Clin. Pharm. Ther. 38, 286-293 (2013).
-
(2013)
J. Clin. Pharm. Ther.
, vol.38
, pp. 286-293
-
-
Fénix-Caballero, S.1
-
88
-
-
84872245667
-
Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: An indirect comparison meta-analysis
-
Thorlund, K., Druyts, E., Aviña-Zubieta, J. A. & Mills, E. J. Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: An indirect comparison meta-analysis. Biologics 6, 417-427 (2012).
-
(2012)
Biologics
, vol.6
, pp. 417-427
-
-
Thorlund, K.1
Druyts, E.2
Aviña-Zubieta, J.A.3
Mills, E.J.4
-
89
-
-
84885182023
-
Switching between TNF inhibitors in psoriatic arthritis: Data from the NOR-DMARD study
-
Fagerli, K. M. et al. Switching between TNF inhibitors in psoriatic arthritis: Data from the NOR-DMARD study. Ann. Rheum. Dis. 72, 1840-1844 (2013).
-
(2013)
Ann. Rheum. Dis.
, vol.72
, pp. 1840-1844
-
-
Fagerli, K.M.1
-
90
-
-
84876572244
-
Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor a inhibitor therapy: Results from the Danish Nationwide DANBIO Registry
-
Glintborg, B. Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor a inhibitor therapy: Results from the Danish Nationwide DANBIO Registry. Arthritis Rheum. 65, 1213-1223 (2013).
-
(2013)
Arthritis Rheum.
, vol.65
, pp. 1213-1223
-
-
Glintborg, B.1
-
91
-
-
84862499912
-
Pharmacoeconomic issues in psoriatic arthritis
-
Olivieri, I. et al. Pharmacoeconomic issues in psoriatic arthritis. J. Rheumatol. Suppl. 89, 103-105 (2012).
-
(2012)
J. Rheumatol. Suppl.
, vol.89
, pp. 103-105
-
-
Olivieri, I.1
-
92
-
-
0035025451
-
Remission in psoriatic arthritis
-
Gladman, D. D., Hing, E. N., Schentag, C. T. & Cook, R. J. Remission in psoriatic arthritis. J. Rheumatol. 28, 1045-1048 (2001).
-
(2001)
J. Rheumatol.
, vol.28
, pp. 1045-1048
-
-
Gladman, D.D.1
Hing, E.N.2
Schentag, C.T.3
Cook, R.J.4
-
93
-
-
0345099477
-
A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience
-
Kane, D., Stafford, L., Bresnihan, B. & FitzGerald, O. A prospective, clinical and radiological study of early psoriatic arthritis: An early synovitis clinic experience. Rheumatology (Oxford) 42, 1460-1468 (2003).
-
(2003)
Rheumatology (Oxford)
, vol.42
, pp. 1460-1468
-
-
Kane, D.1
Stafford, L.2
Bresnihan, B.3
FitzGerald, O.4
-
94
-
-
77952261781
-
Remission in psoriatic arthritis: Is it possible and how can it be predicted?
-
Saber, T. P. et al. Remission in psoriatic arthritis: Is it possible and how can it be predicted? Arthritis Res. Ther. 12, R94 (2010).
-
(2010)
Arthritis Res. Ther.
, vol.12
, pp. R94
-
-
Saber, T.P.1
-
95
-
-
44849131003
-
Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs
-
Cantini, F. et al. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs. Rheumatology (Oxford) 47, 872-876 (2008).
-
(2008)
Rheumatology (Oxford)
, vol.47
, pp. 872-876
-
-
Cantini, F.1
-
96
-
-
84866754677
-
Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: A long-term follow-up study
-
Cantini, F., Niccoli, L., Cassarà, E., Kaloudi, O. & Nannini, C. Sustained maintenance of clinical remission after adalimumab dose reduction in patients with early psoriatic arthritis: A long-term follow-up study. Biologics 6, 201-206 (2012).
-
(2012)
Biologics
, vol.6
, pp. 201-206
-
-
Cantini, F.1
Niccoli, L.2
Cassarà, E.3
Kaloudi, O.4
Nannini, C.5
-
97
-
-
84877823834
-
Can we reduce the dosage of biologics in spondyloarthritis?
-
Olivieri, I. et al. Can. we reduce the dosage of biologics in spondyloarthritis? Autoimmun. Rev. 12, 691-693 (2013).
-
(2013)
Autoimmun. Rev.
, vol.12
, pp. 691-693
-
-
Olivieri, I.1
-
98
-
-
84883134297
-
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
-
McInnes, I. B. et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 382, 780-789 (2013).
-
(2013)
Lancet
, vol.382
, pp. 780-789
-
-
McInnes, I.B.1
-
99
-
-
84873581440
-
Ustekinumab in active psoriatic arthritis including patients previously treated with anti-TNF agents: Results of a phase 3 multicenter, double-blind, placebo controlled-study
-
Ritchlin, C. et al. Ustekinumab in active psoriatic arthritis including patients previously treated with anti-TNF agents: Results of a phase 3 multicenter, double-blind, placebo controlled-study. Arthritis Rheum. 64, S1080-S1081 (2012).
-
(2012)
Arthritis Rheum.
, vol.64
, pp. S1080-S1081
-
-
Ritchlin, C.1
-
100
-
-
84892170359
-
Ustekinumab associated with flares of psoriatic arthritis
-
Stamell, E. F., Kutner, A., Viola, K. & Cohen, S. R. Ustekinumab associated with flares of psoriatic arthritis. JAMA Dermatol. 149, 1410-1413 (2013).
-
(2013)
JAMA Dermatol.
, vol.149
, pp. 1410-1413
-
-
Stamell, E.F.1
Kutner, A.2
Viola, K.3
Cohen, S.R.4
-
101
-
-
84872847067
-
Inflammatory arthritis following ustekinumab treatment for psoriasis: A report of two cases
-
de Souza, A., Ali-Shaw, T., Reddy, S. M., Fiorentino, D. & Strober, B. E. Inflammatory arthritis following ustekinumab treatment for psoriasis: A report of two cases. Br. J. Dermatol. 168, 210-212 (2013).
-
(2013)
Br. J. Dermatol.
, vol.168
, pp. 210-212
-
-
De Souza, A.1
Ali-Shaw, T.2
Reddy, S.M.3
Fiorentino, D.4
Strober, B.E.5
-
102
-
-
84876292569
-
Effect of IL-17A blockade with secukinumab in autoimmune diseases
-
Patel, D. D., Lee, D. M., Kolbinger, F. & Antoni, C. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann. Rheum. Dis. 72 (Suppl. 2) ii116-ii123 (2013).
-
(2013)
Ann. Rheum. Dis.
, vol.72
, pp. ii116-ii123
-
-
Patel, D.D.1
Lee, D.M.2
Kolbinger, F.3
Antoni, C.4
-
103
-
-
84902209516
-
Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis
-
Mease, P.J. et al. Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis. N. Engl. J. Med. 12, 2295-2306 (2014).
-
(2014)
N. Engl. J. Med.
, vol.12
, pp. 2295-2306
-
-
Mease, P.J.1
-
104
-
-
84873168729
-
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase II regimen-finding study
-
Rich, P. et al. Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled, phase II regimen-finding study. Br. J. Dermatol. 168, 402-411 (2013).
-
(2013)
Br. J. Dermatol.
, vol.168
, pp. 402-411
-
-
Rich, P.1
-
105
-
-
84891740105
-
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: A 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
-
McInnes, I. B. et al. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: A 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial. Ann. Rheum. Dis. 73, 349-356 (2014).
-
(2014)
Ann. Rheum. Dis.
, vol.73
, pp. 349-356
-
-
McInnes, I.B.1
-
106
-
-
84988017945
-
-
US National Library of Medicine
-
US National Library of Medicine. ClinicalTrials.gov [online] http://clinicaltrials.gov/show/NCT01695239 (2014).
-
(2014)
ClinicalTrials.gov [online]
-
-
-
107
-
-
84896129404
-
Clinical response to brodalumab, an anti-interleukin-17 receptor antibody, in subjects with psoriatic arthritis
-
Genovese, M. C. et al. Clinical response to brodalumab, an anti-interleukin-17 receptor antibody, in subjects with psoriatic arthritis. Arthritis Rheum. 65 (Suppl. 10), S347-S348 (2013).
-
(2013)
Arthritis Rheum.
, vol.65
, pp. S347-S348
-
-
Genovese, M.C.1
-
108
-
-
84923115890
-
Improvement in psoriasis symptoms and physical functioning with secukinumab compared with placebo and etanercept in subjects with moderate-to-severe plaque psoriasis and psoriatic arthritis: Results of a subanalysis from the phase 3 Fixture study
-
Gottlieb, A. et al. Improvement in psoriasis symptoms and physical functioning with secukinumab compared with placebo and etanercept in subjects with moderate-to-severe plaque psoriasis and psoriatic arthritis: Results of a subanalysis from the phase 3 Fixture study. Arthritis Rheum. 65, 3322 (2013).
-
(2013)
Arthritis Rheum.
, vol.65
, pp. 3322
-
-
Gottlieb, A.1
-
109
-
-
84860175869
-
Apremilast mechanism of action and application to psoriasis and psoriatic arthritis
-
Schafer, P. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis. Biochem. Pharmacol. 83, 1583-1590 (2012).
-
(2012)
Biochem. Pharmacol.
, vol.83
, pp. 1583-1590
-
-
Schafer, P.1
-
110
-
-
84869014252
-
Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study
-
Schett, G. et al. Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 64, 3156-3167 (2012).
-
(2012)
Arthritis Rheum.
, vol.64
, pp. 3156-3167
-
-
Schett, G.1
-
111
-
-
84894898491
-
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis: Results of a phase 3, randomized, controlled trial
-
Kavanaugh, A. et al. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis: Results of a phase 3, randomized, controlled trial. Arthritis Rheum. 64, 4172-4173 (2012).
-
(2012)
Arthritis Rheum.
, vol.64
, pp. 4172-4173
-
-
Kavanaugh, A.1
-
112
-
-
84901833481
-
Long-term (52-week) results of a phase 3, randomized, controlled trial of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis (PALACE 2)
-
Cutolo, M. et al. Long-term (52-week) results of a phase 3, randomized, controlled trial of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis (PALACE 2). Arthritis Rheum. 65 (Suppl. 10), S346 (2013).
-
(2013)
Arthritis Rheum.
, vol.65
, pp. S346
-
-
Cutolo, M.1
-
113
-
-
84901833481
-
Long-term (52-week) results of a phase 3, randomized, controlled trial of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement (PALACE 3)
-
Edwards, C. J. et al. Long-term (52-week) results of a phase 3, randomized, controlled trial of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement (PALACE 3). Arthritis Rheum. 65 (Suppl. 10), S132 (2013).
-
(2013)
Arthritis Rheum.
, vol.65
, pp. S132
-
-
Edwards, C.J.1
-
114
-
-
84901851651
-
Apremilast in the treatment of DMARD-naive psoriatic arthritis patients: Results of a phase 3 randomized, controlled trial (PALACE 4)
-
Wells, A. F. et al. Apremilast in the treatment of DMARD-naive psoriatic arthritis patients: Results of a phase 3 randomized, controlled trial (PALACE 4). Arthritis Rheum. 65, 3320-3321 (2013).
-
(2013)
Arthritis Rheum.
, vol.65
, pp. 3320-3321
-
-
Wells, A.F.1
-
115
-
-
79953701653
-
Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial
-
Mease, P. et al. Abatacept in the treatment of patients with psoriatic arthritis: Results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial. Arthritis Rheum. 63, 939-948 (2011).
-
(2011)
Arthritis Rheum.
, vol.63
, pp. 939-948
-
-
Mease, P.1
-
116
-
-
85029132794
-
Long-term 52-week results of PALACE 1, a phase 3, randomized, controlled trial of apremilast, an oral phosphodiesterase inhibitor, in patients with psoriatic arthritis
-
Adebajo, A. O. et al. Long-term 52-week results of PALACE 1, a phase 3, randomized, controlled trial of apremilast, an oral phosphodiesterase inhibitor, in patients with psoriatic arthritis. Rheumatology 53 (Suppl. 1), i141 (2014).
-
(2014)
Rheumatology
, vol.53
, pp. i141
-
-
Adebajo, A.O.1
-
117
-
-
84867401161
-
Rituximab in psoriatic arthritis: An exploratory evaluation
-
Jimenez-Boj, E. et al. Rituximab in psoriatic arthritis: An exploratory evaluation. Ann. Rheum. Dis. 71, 1868-1871 (2012).
-
(2012)
Ann. Rheum. Dis.
, vol.71
, pp. 1868-1871
-
-
Jimenez-Boj, E.1
-
118
-
-
79958809486
-
Rituximab in psoriatic arthritis provides modest clinical improvement and reduces expression of inflammatory biomarkers in skin lesions
-
Mease, P. et al. Rituximab in psoriatic arthritis provides modest clinical improvement and reduces expression of inflammatory biomarkers in skin lesions. Arthritis Rheum. 62 (Suppl. 10), S818 (2010).
-
(2010)
Arthritis Rheum.
, vol.62
, pp. S818
-
-
Mease, P.1
-
119
-
-
84988017945
-
-
US National Library of Medicine
-
US National Library of Medicine. ClinicalTrials.gov [online] http://clinicaltrials.gov/show/NCT01860976 (2014).
-
(2014)
ClinicalTrials.gov [online]
-
-
-
120
-
-
84870318190
-
Rituximab treatment for spondyloarthritis. A nationwide series: Data from the AIR registry of the French Society of Rheumatology
-
Wendling, D. et al. Rituximab treatment for spondyloarthritis. A nationwide series: Data from the AIR registry of the French Society of Rheumatology. J. Rheumatol. 39, 2327-2331 (2012).
-
(2012)
J. Rheumatol.
, vol.39
, pp. 2327-2331
-
-
Wendling, D.1
-
121
-
-
84882992107
-
Succesful use of tocilizumab in a patient with psoriatic arthritis
-
Hughes, M. & Chinoy, H. Succesful use of tocilizumab in a patient with psoriatic arthritis. Rheumatology 52, 1728-1729 (2013).
-
(2013)
Rheumatology
, vol.52
, pp. 1728-1729
-
-
Hughes, M.1
Chinoy, H.2
-
122
-
-
84855716888
-
Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab
-
Ogata, A., Umegaki, N., Katayama, I., Kumanogoh, A., Tanaka, T. Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab. Joint Bone Spine 79, 85-87 (2012).
-
(2012)
Joint Bone Spine
, vol.79
, pp. 85-87
-
-
Ogata, A.1
Umegaki, N.2
Katayama, I.3
Kumanogoh, A.4
Tanaka, T.5
-
123
-
-
84988017945
-
-
US National Library of Medicine
-
US National Library of Medicine. ClinicalTrials.gov [online] http://clinicaltrials.gov/show/NCT01490450 (2014).
-
(2014)
ClinicalTrials.gov [online]
-
-
-
124
-
-
84865592373
-
Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: A phase 2b randomized placebo-controlled dose-ranging study
-
Papp, K. A. et al. Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: A phase 2b randomized placebo-controlled dose-ranging study. Br. J. Dermatol. 167, 668-677 (2012).
-
(2012)
Br. J. Dermatol.
, vol.167
, pp. 668-677
-
-
Papp, K.A.1
-
125
-
-
84879988459
-
A randomized phase 2a efficacy and safety trial on the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
-
Ports, W. C. et al. A randomized phase 2a efficacy and safety trial on the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis. Br. J. Dermatol. 169, 137-145 (2013).
-
(2013)
Br. J. Dermatol.
, vol.169
, pp. 137-145
-
-
Ports, W.C.1
-
126
-
-
84988017945
-
-
US National Library of Medicine
-
US National Library of Medicine. ClinicalTrials.gov [online] http://clinicaltrials.gov/ct2/show/NCT01882439 (2014).
-
(2014)
ClinicalTrials.gov [online]
-
-
|